Powering a Risk-Based Approach to Clinical Trials
TRI at the Veeva R&D and Quality Summit
TRI is proud to join the Veeva R&D and Quality Summit in Boston as a Product Partner, collaborating with industry leaders to shape the future of clinical trial innovation.
With Risk-Based Quality Management (RBQM) named Veeva’s top priority for the next two years, this summit marks a turning point for the industry, and a powerful opportunity for sponsors to act.
Making RBQM Simple for All Clinical Trials
At TRI, we believe clinical trials thrive when complexity is removed. That’s why our partnership with Veeva is built around one goal: making RBQM simple to adopt, and impactful from day one.
Together, we’re removing the complexity that often holds sponsors back, especially smaller teams who know they need to evolve but aren’t sure where to begin.
RBQM should be accessible to all. That’s why we’ve focused on creating solutions that are scalable and easy to implement, without compromising on impact.
Smarter Oversight, Seamlessly Delivered
Our collaboration with Veeva has enabled something powerful: real-time access to study data through the Veeva API, supported by TRI’s custom data mapping routines. This means clinical teams can engage in centralized monitoring, detect risk signals earlier, and act faster, all without the need for manual data extracts or complex integrations.
It’s a smarter way to work, and it’s already helping sponsors improve data quality, oversight, and patient safety across their trials.
RBQM Essentials: A Confident First Step
For many small and mid-sized sponsors, the challenge isn’t the desire to start, it’s knowing how to start. That’s where the partnership between Veeva and TRI makes a real difference.
- No manual data handling, everything flows through our API and mapping tools
- Instant clarity with dashboards that highlight key risk signals and trends
- Expert onboarding and training provided by TRI
- Ongoing support to keep your study running smoothly
- Flexibility to expand to more study-specific configurations
Whether you’re just beginning your RBQM journey or ready to scale, our Essentials package is designed to meet you where you are, with a risk-based approach that’s both practical and powerful.
What’s Next for TRI and Veeva
This partnership is just getting started. With new releases planned through early 2026, we’re expanding our capabilities to include enhanced reporting, data warehouse integration, and CTMS readiness. We’re also advancing raw data management and module replication, all with the goal of supporting a more intelligent, risk-proportionate approach to clinical trial oversight.
Every update is focused on one thing: helping sponsors manage risk through a more intelligent, ICH E6 R3-aligned approach that supports centralized monitoring for clinical trials.
Let’s Connect in Boston
We’re looking forward to connecting with fellow innovators, sharing insights, and exploring how we can continue to support the industry’s transition to smarter, more efficient trials. If you’re attending the summit, we invite you to meet the TRI team, we’re ready to show you how we’re driving RBQM forward together.